We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Syncona Limited | LSE:SYNC | London | Ordinary Share | GG00B8P59C08 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 122.00 | 121.40 | 122.80 | 122.80 | 120.80 | 120.80 | 352,855 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | -39.79M | -56.02M | -0.0840 | -14.57 | 816.08M |
TIDMSYNC
RNS Number : 2150H
Syncona Limited
30 July 2019
Syncona Limited
Result of Annual General Meeting
30 July 2019
At the Annual General Meeting of the Company held today, all Resolutions as set out in the 'Notice of the 2019 Annual General Meeting' dated 27 June 2019 sent to shareholders of the Company (the "Notice") were duly passed.
Resolutions 1 to 13 were proposed as ordinary resolutions. Resolution 14 was proposed as a Special Resolution and Resolution 15 was proposed as an Extraordinary Resolution.
Details of the proxy voting results, which should be read alongside the Notice, are noted below:
No Resolution For Against Abstain Discretion Receive and consider the Annual Audited Financial Statements of the Company for the year ended 31 March 2019, together with the Reports of the Directors and 1 Auditors thereon 435,492,895 247,369 0 25,774 ------------------------------- ------------ ----------- ---------- ----------- Re-appointment Deloitte LLP (Guernsey Branch) 2 as Auditors 435,511,635 24,433 214,970 15,000 ------------------------------- ------------ ----------- ---------- ----------- Authorise the Directors to determine the remuneration 3 of the Auditors 435,733,447 4,076 2,742 25,774 ------------------------------- ------------ ----------- ---------- ----------- Re-elect Jeremy Tigue 4 as a Director 421,376,075 12,076,117 2,288,072 25,774 ------------------------------- ------------ ----------- ---------- ----------- Elect Melanie Gee 5 as a Director 435,735,679 0 4,586 25,774 ------------------------------- ------------ ----------- ---------- ----------- Re-elect Thomas Henderson 6 as a Director 435,554,836 183,585 1,844 25,774 ------------------------------- ------------ ----------- ---------- ----------- Re-elect Rob Hutchinson 7 as a Director 435,726,044 9,635 4,586 25,774 ------------------------------- ------------ ----------- ---------- ----------- Re-elect Nigel Keen 8 as a Director 435,304,724 430,954 4,586 25,774 ------------------------------- ------------ ----------- ---------- ----------- Re-elect Nick Moss 9 as a Director 435,734,955 724 4,586 25,774 ------------------------------- ------------ ----------- ---------- ----------- Re-elect Gian Piero 10 Reverberi as a Director 435,735,679 0 4,586 25,774 ------------------------------- ------------ ----------- ---------- ----------- Re-elect Ellen Strahlman 11 as a Director 435,735,679 0 4,586 25,774 ------------------------------- ------------ ----------- ---------- ----------- Approve the directors' 12 remuneration report. 435,688,593 49,828 1,844 25,774 ------------------------------- ------------ ----------- ---------- ----------- Authority to allot 13 shares 435,723,353 12,326 4,586 25,774 ------------------------------- ------------ ----------- ---------- ----------- Authorise the Company to purchase its own 14 shares 435,722,250 12,693 2,742 28,354 ------------------------------- ------------ ----------- ---------- ----------- Disapply pre-emption 15 rights 435,720,338 1,987 4,586 39,128 ------------------------------- ------------ ----------- ---------- -----------
A vote withheld is not a vote in law and has not been counted in the votes for and against a resolution.
In accordance with the Listing Rule 9.6.2, a copy of all the resolutions passed other than resolutions concerning ordinary business have been submitted to the UK Listing Authority via the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.
The full text of the resolutions can be found in the Notice, which is available on the Company's website at www.synconaltd.com/investors.
[ENDS]
Enquiries
Syncona Ltd
Siobhan Weaver / Annabel Clay
Tel: +44 (0) 20 3981 7940
FTI Consulting
Brett Pollard / Natalie Garland-Collins
Tel: +44 (0) 20 3727 1000
Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com.
About Syncona:
Syncona is a leading FTSE250 healthcare company focused on investing in and building global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.
We take a long-term view, underpinned by a deep pool of capital, and are established leaders in the development of gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RAGWGUPAMUPBGUU
(END) Dow Jones Newswires
July 30, 2019 06:56 ET (10:56 GMT)
1 Year Syncona Chart |
1 Month Syncona Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions